Small Molecule
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
72
NCT03903302
Study Investigation Pharmacokinetics and Pharmacodynamics of CS1
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 6, 2017
Completion: Mar 27, 2018
NCT04726514
SleepFlexTM Treatment of Obstructive Sleep Apnea
Phase: N/A
Start: Jul 20, 2021
Completion: May 31, 2022
NCT05224531
Effect of CS1 in Subjects With Pulmonary Arterial Hypertension
Phase: Phase 2
Start: May 5, 2022
Completion: Aug 1, 2024
NCT06907693
The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI
Role: Collaborator
Start: Mar 14, 2025
Completion: Jan 15, 2026
Loading map...